Two completely different things called stem cell therapy
The science: Parkinson's involves loss of dopamine-producing neurons in a specific brain region. Researchers have learned to turn pluripotent stem cells (embryonic or induced) into dopaminergic neuron precursors and surgically implant them into that region, where they can survive, connect, and produce dopamine. Phase 1 and early Phase 2 results published in 2024 and 2025 from programs in the US, Japan and Sweden showed cell survival on imaging, acceptable safety, and early signs of motor improvement in some participants. This is genuine, and it is done only in registered trials with neurosurgical implantation and immunosuppression.
The clinic product: mesenchymal stem cells from umbilical cord, fat or bone marrow, infused intravenously or injected into the spinal fluid. These cells do not become neurons, do not reach the affected brain region in meaningful numbers after IV infusion, and are not what the trials above use. Any benefit claimed is attributed to anti-inflammatory or trophic effects. Controlled evidence for that in Parkinson's is essentially absent.
What the trial data actually show
- Dopaminergic precursor grafts survive and take up tracer on PET scans
- No tumor formation reported in the published cohorts so far
- Some participants improved on motor scales off medication; the studies were not designed to prove efficacy and had no placebo arm
- Larger, controlled Phase 2 and 3 trials are recruiting; the earliest realistic approval timeline is late this decade
What clinic marketing does with this
Brochures cite the trial results and then offer an IV MSC infusion, as if they were the same therapy. They are not. This is the single most common sleight of hand in neurologic stem cell marketing. If a clinic offers Parkinson's treatment, ask: "Are you implanting dopaminergic neurons into the putamen under a registered protocol, or infusing mesenchymal cells?" The answer settles it.
Red flags specific to Parkinson's offers
- IV or intrathecal MSCs described as "regenerating dopamine neurons"
- Testimonial videos filmed shortly after treatment, when placebo response and medication timing dominate
- Packages combining stem cells with unrelated add-ons (ozone, chelation, high-dose vitamins)
- No neurologist on the treating team
- Price quoted per "cell count" rather than per protocol
Legitimate options for a patient today
- Optimized medical management with a movement disorder specialist
- Deep brain stimulation, which has L1 evidence for motor symptoms in appropriate candidates and is available in Colombia at major centers at a fraction of US cost
- Focused ultrasound for tremor-dominant disease
- Enrollment in a dopaminergic cell transplant trial if you meet criteria; see finding legitimate trials
Colombia specifically
Colombia has excellent neurology and functional neurosurgery, including deep brain stimulation programs. It does not have an approved or trial-based dopaminergic transplant program open to foreign patients as of 2026. Clinics advertising Parkinson's stem cell therapy in Colombia are offering MSC infusions, graded L4 for this indication. We do not refer patients for that. We will help you access DBS evaluation or a neurologist consultation; see neurological conditions in Colombia.
Regulatory status: FDA vs INVIMA
United States (FDA): The only FDA-approved stem cell products are hematopoietic (blood-forming) cell products for blood cancers and immune disorders. There is no approved stem cell therapy for stroke, cerebral palsy, brain injury, Parkinson's disease, macular degeneration or hearing loss. Legitimate access in the US is through registered clinical trials listed at ClinicalTrials.gov.
Colombia (INVIMA): Cell therapies fall under advanced-therapy regulation. Facilities need INVIMA habilitation and laboratory-processed cell products need product authorization or an approved research protocol. Verify the clinic's INVIMA status and the physician's ReTHUS registration. Neurologic indications are experimental everywhere; a Colombian clinic offering them outside a documented protocol should be treated with corresponding caution.
Frequently asked questions
Is there a stem cell cure for Parkinson's?
No. Dopaminergic neuron transplant trials are promising but early and unproven. Clinic MSC infusions are not the same therapy and lack controlled evidence.
Can I get the trial therapy in Colombia?
Not as of 2026. The transplant trials are at specific academic sites in the US, Europe and Japan.
What works for Parkinson's in Colombia?
Specialist medical management and deep brain stimulation, both with strong evidence and available at major Colombian centers.
Living with Parkinson's and researching options?
We will not sell you an infusion. We can connect you with a Colombian movement disorder specialist or DBS program for an honest second opinion.
WhatsApp Andy in MedellínRequest a quote